- This PRISMA-ScR scoping review screened 2,187 records and included 12 studies of ketamine with pain and depression outcomes assessed longitudinally.
- Eight studies enrolled chronic pain patients and four enrolled depression-primary populations, while acute, perioperative, perinatal, and cancer-related pain were excluded.
- Most studies reported concurrent improvement in pain and depressive symptoms, but the abstract gives no pooled effect size.
- The authors conclude that heterogeneity in populations, dosing, design, and comorbidity prevents inferring that depression modifies ketamine's analgesic effect, and call for randomized trials.
Chronic pain
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This systematic scoping review screened 4,344 records and included 29 unique studies (21 articles and 12 protocols) of mHealth interventions for adults with chronic non-cancer pain.
- Included interventions were mainly mobile apps (n = 14), followed by text messaging (n = 5) and telephone interactive voice response (n = 3).
- Opioid use was an eligibility criterion in 14 studies, and seven were designed specifically to support opioid tapering.
- Published results reported high acceptability and feasibility with potential efficacy, and the authors call for future studies to evaluate efficacy and mediating or moderating factors.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
- This narrative review synthesises mechanistic evidence from human tissue analyses, advanced neuroimaging, and deep clinical phenotyping in entrapment neuropathies, the most prevalent focal neuropathic pain conditions.
- The authors describe these disorders as biologically dynamic, involving microvascular compromise, demyelination, axonal degeneration, immune dysregulation, neuroinflammation, central adaptations, and psychosocial influences.
- Varying combinations of these processes are proposed to explain clinical heterogeneity within one diagnosis and discordances such as normal electrodiagnostic findings or imaging-symptom mismatch.
- The authors argue that surgical decompression offers a natural model of focal nerve injury and that mechanism-informed management may be needed, since one-size-fits-all treatments have largely failed.
- This perspective article proposes a conceptual framework for pediatric chronic pain research and care, rather than reporting new empirical data.
- The BRIDGE framework combines biobehavioral mechanistic research with digital monitoring, such as wearable sensors and ecological momentary assessment, and guided patient engagement.
- The authors argue that these tools could identify modifiable mechanisms, digital biomarkers of risk and recovery, and support precision and adaptive treatment.
- They emphasize that partnership with youth and families is central, so that measurement and interventions stay aligned with patient priorities and lived experience.
- This is a narrative review by a pain researcher accepting a 2026 lifetime achievement prize, summarizing four decades of animal-model work.
- It covers gene expression changes related to neuroplasticity in dorsal root ganglion and spinal cord, using morphological, molecular, behavioral, and electrophysiological methods.
- The abstract reports no quantitative results, effect sizes, or statistics; it describes the scope of the review and planned discussion of methods and future directions.
- This invited viewpoint synthesizes contributors to pain inequity in low- and middle-income countries and among cultural minority groups in high-income settings.
- Proposed remedies include education of health professionals and the public, culturally and linguistically responsive assessment, contextually adapted self-management, and standardized collection of sociodemographic data.
- The author proposes principles for North-South collaboration, including co-created research agendas, shared leadership, sustainable capacity building, and transparent governance.
- The conclusion calls for coordinated action across clinicians, researchers, institutions, policymakers, journals, funders, and communities.
- This article is a discussion piece on neuropathic pain, not a primary study, so it reports no trial data or effect sizes.
- It argues that heterogeneous neuropathic pain mechanisms, not only etiology, may explain repeated trial failures and suggests mechanism-based reclassification.
- It notes that no validated biomarkers for pain mechanisms currently exist, so it discusses surrogate markers such as patient-reported sensory symptoms and sensory testing.
- The authors propose integrating these candidate predictive and surrogate markers into future clinical trials to identify likely treatment responders.
- This narrative review synthesizes work on human nociceptor diversity, linking microneurography, patch-clamp electrophysiology, and single-cell transcriptomics.
- It discusses transferring microneurography hallmarks, such as activity-dependent slowing and recovery cycles, into in vitro patch-clamp paradigms, with Patch-seq assigning molecular identity to functional subtypes.
- The mechano-insensitive 'sleeping' nociceptor is offered as an example of a functionally defined subtype characterized molecularly.
- The authors argue that integrating human nerve fiber function with molecular programs, including sodium channel subtypes, could enable stratified, mechanism-based neuropathic pain therapies.
- This is an updated perspective article reviewing how exercise may act on the mesocorticolimbic system in chronic pain.
- It proposes three routes: myokines such as IGF-1 acting through orexin and VTA dopamine neurons, amygdala circuits, and dorsal raphe serotonin neurons.
- No sample sizes, effect sizes, or confidence intervals are reported, so the supporting evidence is described only qualitatively.
- The authors conclude that exercise therapy should be a key component of chronic pain management, and propose epigenetic changes as a basis for lasting effects.
- This review examines drug combination therapy for pain, drawing on preclinical synergy studies, real-world prescribing data, and many randomized trials across several pain conditions.
- Combining drugs from different mechanistic classes is proposed to give superior analgesia and possibly fewer side effects than monotherapy, based on preclinical synergy.
- Real-world data reportedly show that about half of patients with chronic pain, and more with acute pain, receive two or more drugs from different classes.
- The authors argue that many analgesic combinations lack rigorous evidence and propose five priorities, including trials that compare each monotherapy component.
- This perspective article synthesizes pharmacology, neural recording, and causal manipulation evidence on spontaneous neuropathic pain and presents no original sample or data.
- It describes injured-fiber ectopic activity in specific sensory neuron subtypes as a dominant peripheral generator of spontaneous pain, separate from spared-fiber pathways that drive evoked hypersensitivity.
- The authors argue spontaneous neuropathic pain should be defined as its own symptom domain, because most therapies were validated on evoked or overall intensity endpoints.
- They propose longitudinal, biomarker-informed phenotyping to capture fluctuating pain and support mechanism-based, symptom-aligned treatments.
- This is a translational review combining clinical evidence and preclinical mechanistic models on postsurgical pain prediction and prevention.
- It covers perioperative bio-psycho-social risk factors for acute-to-chronic postsurgical pain, plus emerging biological signatures for risk stratification.
- The authors argue that current risk assessment tools lack sufficient precision, reliability, and generalizability, and that risk evolves across pre-, intra-, and postsurgical phases.
- They propose integrating bio-psycho-social factors into clinically relevant prognostic models to support mechanism-based, personalized prevention in vulnerable patients.
- This narrative review synthesizes animal and human studies on the brain sites involved in endogenous pain modulation.
- It focuses on the best-characterised pathway, running from the midbrain periaqueductal gray to the rostral ventromedial medulla and then to the dorsal horn or spinal trigeminal nucleus.
- These circuits are conserved and can modulate pain largely independently of cortex, though the prefrontal cortex can influence them, and their organisation may change in persistent pain.
- Ultra-high-field fMRI now allows imaging of brainstem nuclei at millimetre-cubed scale, which standard MRI's limited resolution had previously prevented.
- This paper summarises the ENTRUST-PE framework, developed by an international, interdisciplinary network to enhance trustworthiness in pain research.
- The framework proposes seven core values, including methodological rigour, openness and transparency, and patient and public involvement, with recommendations for different interest holders.
- The authors reflect on the community's response since the 2024 launch and consider challenges and opportunities in the evolving research landscape.
- They suggest how the field might move toward deeper implementation of the framework.
- This narrative review synthesizes mechanistic work on chloride dysregulation in chronic pain, and the abstract reports no sample size or clinical data.
- It focuses on injury-induced downregulation of the potassium-chloride cotransporter KCC2 in spinal dorsal horn neurons as a substrate for loss of spinal inhibition.
- The authors argue that chloride dysregulation could explain neuropathic pain features such as hyperalgesia, allodynia, and spontaneous pain, and could account for benzodiazepine analgesic failure.
- They conclude that KCC2 is a promising novel target for both analgesia and disease modification in chronic pain.
- Systematic review and meta-analysis of 8 randomized controlled trials including 543 adults, comparing short-term peripheral nerve stimulation with sham or usual care.
- The primary outcome was change in average pain intensity during the implantation period.
- Average pain fell during implantation at 1-4 weeks (SMD -0.48, 95% CI -0.71 to -0.26) and 5-8 weeks (SMD -0.96, 95% CI -1.22 to -0.70), but not after electrode removal.
- The authors describe the evidence as preliminary: pain relief occurs during implantation, but not all outcomes show benefit that persists after removal.
- Systematic review and meta-analysis of 40 studies comparing adults with and without opioid use disorder undergoing surgery.
- Primary outcomes were postoperative pain and composite adverse respiratory events, drawn from three and 19 studies respectively.
- Opioid use disorder was associated with higher odds of postoperative pain (OR 2.87, 95% CI 1.63-5.06) and adverse respiratory events (OR 2.10, 95% CI 1.64-2.68), both rated moderate certainty.
- Lower-certainty evidence suggested higher readmission, longer stay and higher costs, with no significant mortality difference; the authors support routine preoperative screening.
- This is a narrative discourse rather than a trial, reviewing debates on radiofrequency ablation of the genicular nerves for chronic knee osteoarthritis pain.
- It addresses six controversies: prognostic blocks, final cannula placement, which nerves to target, ultrasound versus fluoroscopy, pulsed radiofrequency, and use after knee arthroplasty.
- The abstract notes earlier studies reporting pain relief lasting up to 12 months, while recent randomized trials have questioned RFA efficacy.
- The authors attribute conflicting results partly to heterogeneity in patient selection and technical protocols, and aim to guide clinicians and prompt further research.
- This systematic review pooled prospective randomized trials and observational studies of preoperative genicular nerve radiofrequency ablation before total knee arthroplasty.
- The comparison was ablation against control procedures, assessing function, pain, opioid use, length of stay, and complications.
- Trials showed no meaningful improvement in medium- to long-term function, acute pain, or length of stay, and no clear rise in complications was found.
- Retrospective data hinted at fewer long-term opioid refills, but no study stratified outcomes by baseline risk, so high-risk patients remain untested.
- This PRISMA-ScR scoping review of 199 studies (2010 to August 2025) mapped weight-loss strategies in adults with obesity and hip or knee osteoarthritis.
- Of the included studies, 36 (18.1%) directly assessed GLP-1 receptor agonists, and only 14 of those reported original data.
- Most GLP-1 studies (29/36) were published in 2024–2025, and 19/36 were level 5 evidence; knee data showed weight loss and pain/function gains, while hip data were sparse.
- The authors call GLP-1 receptor agonists a promising adjunct and advise using them within supervised, multimodal musculoskeletal care rather than as standalone weight-loss agents.
- This scoping review synthesized 63 eligible studies on suicidality in people with chronic noncancer pain and co-occurring substance use or SUD, searched across five databases.
- The review charted the literature rather than testing an intervention, so it reports no pooled effect estimates or comparator results.
- Studies were mostly cross-sectional, community samples were underrepresented, and most were from the United States; five themes emerged, including untreated pain and stigma.
- The authors identified gaps in standardized suicidality assessment, rigorous study designs, and representative samples, and proposed future research directions.
- This narrative practical review synthesizes indirect pharmacological and adjacent procedural evidence, with no dedicated comparative trial of local anesthetics within RFA.
- It suggests lidocaine 1% as a default for skin and track anesthesia, and avoiding lidocaine 2% near the target nerve where stimulation testing is done, based on mechanistic reasoning.
- Across five randomized trials outside interventional pain settings, premixing lidocaine and bupivacaine showed no onset advantage over bupivacaine alone and sometimes shortened duration.
- The authors conclude these considerations are provisional and call for prospective studies, and they provide an allergy substitution pathway centered on formal allergist evaluation.
- Descriptive review of 288 neuropathic pain RCTs of pharmacotherapy and neuromodulation, of which 36 (12.5%) reported a blinding assessment.
- The 37 studies with a blinding assessment were mostly crossover (19) or parallel (17) designs; all assessed participant blinding, and 10 also assessed investigators.
- Using the Bang Blinding Index in 17 trials, 10 of 17 placebo and 10 of 17 treatment arms remained blinded (BI = 0 ± 0.2).
- The authors conclude that blinding assessments are uncommon and methodologically variable, and they call for consensus on how to conduct and interpret them.
- This overview reviews health economic principles and published full and partial economic evaluations of intrathecal drug delivery (ITDD) systems across cancer pain, chronic non-cancer pain, and spasticity.
- ITDD is compared with conventional management strategies, and the analyses span varying perspectives and healthcare settings.
- Most analyses suggest ITDD is cost-effective, particularly for cancer-related pain and spasticity, though the authors caution that findings rest on heterogeneous methods and often small or uncontrolled effectiveness data.
- Evidence for chronic non-cancer pain is sparse and inconsistent, and the authors call for comparative effectiveness research and long-term economic modeling.
- This practical guide synthesizes evidence, consensus recommendations, and international clinical experience on intrathecal drug delivery for refractory pain.
- It covers preimplant evaluation, trialing, pump and catheter selection, perioperative care, early troubleshooting, long-term maintenance, and complication surveillance.
- It reviews intrathecal opioids, local anesthetics, ziconotide, clonidine, and baclofen, with attention to indication-specific dosing and safety, but reports no pooled quantitative results.
- It frames outcomes beyond pain intensity, including function, quality of life, and reduced systemic medication use, and addresses cancer and non-cancer populations separately.
- This narrative review searched five databases and screened studies with three reviewers, then synthesized them descriptively due to heterogeneity.
- It examines intrathecal drug delivery systems for less common refractory pain, including spinal cord injury pain, transverse myelitis, diabetic neuropathy, postherpetic neuralgia and craniofacial pain.
- The authors found the evidence rests mainly on observational studies and small trials, with possible meaningful relief in selected patients but variable magnitude and durability of response.
- They conclude the evidence is limited, that selective clinical use may contribute to this gap, and that future research is needed to define its role.
- This is a structured critical review of the 2024 ASIPP consensus guideline, built from literature review, evidence synthesis, and modified Delphi voting.
- It summarizes recommendations on stopping, bridging, and resuming antiplatelet and anticoagulant drugs, with 50 interventional procedures stratified by composite risk score.
- Of the 50 procedures, 19 were classed low-risk, 7 moderate-risk, and 24 high-risk, and 16 of 18 recommendations reached unanimous panel acceptance.
- The authors favor selective rather than routine cessation, especially for low-risk procedures, while acknowledging uncertainty about procedure classifications and interruption intervals.
- This is a narrative review of PubMed literature on macrophage mechanisms in the CNS and DRG in postherpetic neuralgia, with no primary data.
- It identifies microglial activation in the spinal dorsal horn and macrophage expansion in the DRG as major proposed mechanisms underlying PHN.
- Symptomatic treatments reviewed include medications, nerve blocks, and neuromodulation, while etiological approaches focus on autologous biomaterials such as fat, BMAC, plasma, and serum.
- The authors note that autologous biomaterial therapies lack multicenter, large-sample, high-quality studies, and they call for better interventions for refractory PHN.
- This narrative review pooled 9 case report and case series articles, covering 27 amputees treated with spinal cord stimulation for pain-related symptoms.
- The review compared no alternative treatment; it examined SCS as the intervention for phantom limb pain across upper and lower limb amputations.
- Combined pain scores fell by a mean of 60.1% (SD 27.6), and only one included study assessed function before and after surgery.
- The authors conclude SCS appears to be a favorable option for phantom limb pain and may have a role in somatosensory feedback.
- This narrative health policy review synthesizes the CY 2026 final rule, CY 2027 proposed rule, and Medicare cost and utilization data, without patient-level data or statistical testing.
- It examines the CY 2026 rule's cut in indirect practice expense for facility services to 50% of the non-facility amount.
- Inflation-adjusted Medicare payment fell about 41% in interventional pain management from 2001 to 2025, while practice costs rose 59% by the Medicare Economic Index.
- The authors argue the facility/non-facility split poorly captures who bears indirect costs and propose an independent-practice modifier instead.
- This narrative policy review examines the CY 2027 OPPS/ASC proposed rule (CMS-1850-P) and prior Pain Physician analyses, focused on interventional pain management.
- Alongside a 2.4% ASC update, neuromodulation codes such as SCS generator insertion (+14.8%) get large proposed increases, but multiple-procedure discounts may offset them.
- Core injection-based procedures, including epidural steroid injections, facet joint injections, and facet radiofrequency ablation, are proposed to decrease by 3.8% to 4.3%.
- The authors conclude the proposed trajectory favors device-based procedures in ASCs over hospital outpatient departments, while injection-based services face compounding erosion in relative payment.
- Narrative policy review of CMS's Ambulatory Specialty Model, a mandatory payment model covering heart failure and low back pain, with no study population or sample size reported.
- The review describes ASM's physician selection, episode-based cost adjustments by site of service, quality and PROM requirements, and Collaborative Care Arrangement rules, comparing it with MIPS and ACOs.
- The abstract reports no quantitative results; instead it weighs whether ASM is a carrot-and-stick or aversion-based policy and whether it represents innovation or limitation.
- It focuses on implications for interventional pain management, including comparisons across specialties such as neurosurgery and pain medicine, and ends with a practical action list for practices.
- This is a methodological review of in vivo fiber photometry for measuring nociceptive state across the brain and spinal cord in rodent models.
- It weighs the advantages of longitudinal, cell-type-specific recording during free movement against systematic error sources that are amplified in pain paradigms.
- Key constraints include a heterogeneous sampling volume, somatic-neuropil signal mixing, indicator kinetics that blur spiking, and motion, photobleaching, or hemodynamic artifacts that can mimic neural responses.
- The authors stress reference channels, artifact correction, behavioral alignment, and transparent reporting, and flag the parabrachial nucleus, periaqueductal gray, and anterior cingulate cortex as targets.
- This is a Perspective article that reports no new data, sample, or outcomes; it argues about sham controls in acupuncture pain trials.
- It proposes random-point acupuncture, where real needling is applied at randomly chosen points unrelated to the treatment protocol, as an alternative to superficial needling or non-penetrating sham devices.
- The authors argue that sham approaches may not be physiologically inert, so they could blunt treatment-control differences, and that random-point controls could preserve blinding while allowing direct tests of acupoint specificity.
- They conclude that this design could strengthen trial rigor and clarify mechanisms of acupuncture analgesia, but this remains a proposal without empirical validation in the abstract.
- A qualitative evidence synthesis of 22 studies covering 292 children aged 6-18 and 194 parents, 84% of whom were mothers.
- It examined perceptions of factors shaping therapeutic interactions with health professionals during chronic pain care, synthesised thematically.
- One overarching theme with six sub-themes emerged; of 14 findings, 5 (36%) had moderate, 8 (57%) low, and 1 (7%) very low GRADE-CERQual confidence.
- The authors conclude that past pain care experiences shape future engagement and propose a conceptual framework to help clinicians nurture therapeutic interactions.
- This PRISMA systematic review pooled 19 studies, including sham-controlled trials, active-comparator trials and cohorts, of genicular nerve block and radiofrequency ablation for knee osteoarthritis.
- Pooled random-effects meta-analysis was used where data were homogeneous, and structured narrative synthesis otherwise.
- RFA was associated with larger and more durable pain relief than GNB, often lasting 6-12 months, though most of the comparison evidence is indirect.
- Both approaches reduced pain with no serious procedure-related adverse events reported, and the authors call for head-to-head trials with standardised protocols and longer follow-up.
- The article draws on animal and human studies to examine the hippocampus's role in pain; the abstract does not state the study design or sample.
- No intervention, comparator, or exposure is described; the paper appears to be a broad synthesis of existing work.
- The authors state that current evidence positions the hippocampus as a key contributor to the pain experience, with no effect sizes or statistics reported.
- They aim to offer conceptual insight and novelty for future interdisciplinary pain research.